In 2007, Pellett et al first reported that the frequency of KIR 2DS1 was significantly increased in SLE patients compared with controls.[23] Since then, the association between KIR polymorphism and SLE susceptibility has been replicated in many studies, and some may be inconsistent and population specific. Here, KIR3DL1 is linked to systemic lupus erythematosus.